Sino Biopharmaceutical (OTCMKTS:SBMFF – Get Free Report) shares reached a new 52-week low during trading on Thursday . The company traded as low as $0.5928 and last traded at $0.5928, with a volume of 2500 shares trading hands. The stock had previously closed at $0.6331.
Sino Biopharmaceutical Stock Performance
The company has a fifty day simple moving average of $0.67 and a two-hundred day simple moving average of $0.78.
About Sino Biopharmaceutical
Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.
The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.
Featured Articles
- Five stocks we like better than Sino Biopharmaceutical
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
